18.06.2015 Views

puramatrix in vivo delivery protocol with and without cells - 3DM Inc.

puramatrix in vivo delivery protocol with and without cells - 3DM Inc.

puramatrix in vivo delivery protocol with and without cells - 3DM Inc.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PURAMATRIX TM<br />

IN VIVO DELIVERY PROTOCOL<br />

WITH AND WITHOUT CELLS<br />

IN VIVO DELIVERY OF CELLS ENCAPSULATED WITHIN PURAMATRIX:<br />

Cells can be delivered <strong>with</strong> PuraMatrix <strong>in</strong> <strong>vivo</strong>, <strong>with</strong> no expansion of the <strong>in</strong>jected gel volume either <strong>in</strong> the<br />

syr<strong>in</strong>ge or upon <strong>delivery</strong> <strong>in</strong>to tissue. We recommend the follow<strong>in</strong>g <strong>protocol</strong> below that <strong>in</strong>volves pre-gell<strong>in</strong>g<br />

the <strong>cells</strong> <strong>with</strong> PuraMatrix followed by <strong>delivery</strong> <strong>in</strong> <strong>vivo</strong>. Below is an example of prepar<strong>in</strong>g 200 µL, 0.25 %<br />

PuraMatrix. Adjust concentration <strong>and</strong> volume as required.<br />

1. LIQUIFY: Sonicate PuraMatrix solution <strong>in</strong> a bath sonicator for 30 m<strong>in</strong>utes to decrease viscosity.<br />

2. CELL HARVEST: Harvest <strong>cells</strong> by low-speed centrifugation. Remove media.<br />

3. SALT-FREE WASH & ISO-OSMOTIC SUCROSE RESUSPENSION: Add<br />

1/4 f<strong>in</strong>al volume (e.g. 50 µL) of 10% sucrose to cell pellet <strong>and</strong> resuspend<br />

<strong>cells</strong> to a 4x cell concentration of the f<strong>in</strong>al <strong>in</strong>jection. Centrifuge <strong>and</strong> discard<br />

supernatant. Repeat this step to ensure removal of high-salt solution, i.e.<br />

media, to avoid premature gelation of PuraMatrix <strong>in</strong> the next step.<br />

4. CELL ENCAPSULATION WITHIN PURAMATRIX: Add 1/4 f<strong>in</strong>al<br />

volume (50 µL) PuraMatrix (packaged as 1%) <strong>in</strong> deionized<br />

water (left) <strong>and</strong> QUICKLY comb<strong>in</strong>e <strong>with</strong> cell suspension <strong>in</strong><br />

sucrose (right).<br />

5. QUICKLY mix well by gentle pipett<strong>in</strong>g.<br />

6. PURAMATRIX GELATION, PH BUFFERING & SCAFFOLD ASSEMBLY: Layer 1/2 f<strong>in</strong>al<br />

volume (100 µL) of 1.0X PBS on cell/sucrose/PuraMatrix. This process <strong>in</strong>itiates gelation<br />

of PuraMatrix <strong>in</strong> the tube.<br />

7. Gently mix two layers by pipett<strong>in</strong>g-the f<strong>in</strong>al volume should be 200 µL <strong>with</strong> the <strong>cells</strong> at 1X<br />

concentration <strong>and</strong> the PuraMatrix at 0.25%.<br />

8. SYRINGE LOADING: Pull the mixture <strong>in</strong>to a syr<strong>in</strong>ge <strong>with</strong> 20G needle. Use of large needle is<br />

recommended to avoid form<strong>in</strong>g bubbles.<br />

9. Change needle to 26 or 30G <strong>and</strong> <strong>in</strong>ject <strong>in</strong> tissue of choice.<br />

3 DM, INC • PO BOX 425025 • CAMBRIDGE, MASSACHUSETTS • 02445 USA<br />

WWW.PURAMATRIX.COM EMAIL: CONTACT@PURAMATRIX.COM • PHONE: 877.430.9595 • FAX: 877.430.9595


– 2 –<br />

PURAMATRIX TM<br />

IN VIVO DELIVERY PROTOCOL WITHOUT CELLS<br />

SUCROSE ADDITION FOR IN VIVO ADMINISTRATION:<br />

In order to reta<strong>in</strong> the osmotic balance of <strong>in</strong>jected tissue, we recommend add<strong>in</strong>g sucrose to the PuraMatrix<br />

solution to achieve a f<strong>in</strong>al concentration of 10% sucrose.<br />

1. Add 100 mg sucrose (Mall<strong>in</strong>ckrodt, catalog #: MK772302) per 1 ml PuraMatrix solution (f<strong>in</strong>al<br />

concentration of 10%).<br />

2. Pipette up <strong>and</strong> down to mix <strong>and</strong> dissolve sucrose.<br />

3. Load PuraMatrix sucrose mix <strong>in</strong>to syr<strong>in</strong>ge. For syr<strong>in</strong>ge fill<strong>in</strong>g, we recommend a 20 G needle <strong>with</strong> a 1<br />

ml syr<strong>in</strong>ge. Change needle to 30G <strong>and</strong> <strong>in</strong>ject <strong>in</strong>to tissue of <strong>in</strong>terest.<br />

DELIVERY OF PRE-GELLED PURAMATRIX AT PH 7.2:<br />

PuraMatrix can also be pre-gelled <strong>in</strong> tubes for <strong>delivery</strong> <strong>in</strong> <strong>vivo</strong>. PuraMatrix gels at pH 4.5-5.0 or<br />

greater. No further gellation will occur <strong>in</strong> <strong>vivo</strong> after <strong>in</strong>jection <strong>and</strong> this procedure will result <strong>in</strong> the <strong>in</strong>jection<br />

of PuraMatrix gel fragments, hence a less cohesive bolus <strong>in</strong> <strong>vivo</strong>.<br />

1. Aliquot 500 µl of PuraMatrix <strong>in</strong>to a microtube.<br />

2. Slowly add 1.0 ml PBS over the top of the PuraMatrix.<br />

3. Let sit for 10-12 hours <strong>and</strong> change PBS. pH of gelled PuraMatrix will reach equilibrium <strong>with</strong><strong>in</strong> 24-48<br />

hours.<br />

<strong>3DM</strong>, INC • PO BOX 425025 • CAMBRIDGE, MASSACHUSETTS • 02445 USA<br />

WWW.PURAMATRIX.COM • EMAIL: CONTACT@PURAMATRIX.COM • PHONE: 877.430.9595 • FAX: 877.430.9595


– 3 –<br />

REFERENCES LATEST PROTOCOLS & PUBLICATIONS AT WWW.PURAMATRIX.COM<br />

1) Narmoneva, D., Oni, O., Siem<strong>in</strong>ski, AL, Zhang, S., Gertler, JP, Kamm, RD, Lee, RT Self-assembl<strong>in</strong>g short<br />

oligopeptides <strong>and</strong> the promotion of Angiogenesis. Biomaterials 26: 4837–4846 (2005).<br />

2) Mauck RL, Helm JM, Tuan RS. Enhanced Chondrogenesis <strong>and</strong> Development of Mechanical Properties of<br />

Human Mesenchymal Stem Cells Seeded <strong>in</strong> a Self-Assembl<strong>in</strong>g Peptide Hydrogel. Summer Bioeng<strong>in</strong>eer<strong>in</strong>g<br />

Conference, Vail, CO. (2005).<br />

3) Bokhari, MA., Akay G., Zhang S.,Birch, MA. The enhancement of osteoblast growth <strong>and</strong> differentiation <strong>in</strong> vitro<br />

on a peptide hydrogel—polyHIPE polymer hybrid material. Biomaterials 26: 5198–5208 (2005).<br />

4) Davis, ME, Motion, JPM, Narmoneva, D., Takahashi, T., Hakuno, D., Kamm, RD, Zhang, S., Lee, RT. Injectable<br />

Self-Assembl<strong>in</strong>g Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells.<br />

Circulation 111:442-450 (2005).<br />

5) Narmoneva, DA, Vukmirovic, R., Davis, ME, Kamm, RD, Lee, RT. Endothelial Cells Promote Cardiac Myocyte<br />

Survival <strong>and</strong> Spatial Reorganization, Implications for Cardiac Regeneration. Circulation 110:962-968 (2004).<br />

6) Sem<strong>in</strong>o, CE, Kasahara, J., Hayashi, Y., Zhang, S. Entrapment of Migrat<strong>in</strong>g Hippocampal Neural Cells <strong>in</strong> Three-<br />

Dimensional Peptide Nanofiber Scaffold. Tissue Eng<strong>in</strong>eer<strong>in</strong>g Vol 10: 643-655 (2004).<br />

7) Kiyonaka, S., Sada, K., Yoshimura, I., Sh<strong>in</strong>kai, S., Kato, N., Hamachi, I. Semi-wet peptide/prote<strong>in</strong> array us<strong>in</strong>g<br />

supramolecular hydrogel. Nature Materials 3: 58-64 (2004).<br />

8) Sem<strong>in</strong>o, Carlos. Can we build artificial stem cell compartments? J. Biomed Biotechnol. 3:164-169 (2003).<br />

9) Rich, A., Zhang, S. Z-DNA: the long road to biologic function. Nature Reviews: Genetics Vol. 4: 566-573 (2003).<br />

10) Sem<strong>in</strong>o, C.E., Merok, J., Crane, G., Panagiotakos, G., Zhang, S. Functional differentiation of hepatocyte-like<br />

spheroid structures from putative liver progenitor <strong>cells</strong> <strong>in</strong> three-dimensional peptide scaffolds. Differentiation<br />

71:262–270 (2003).<br />

11) Kisiday, J., J<strong>in</strong>, M., Kurz, B., Hung, H., Sem<strong>in</strong>o, C., Zhang, S. & Grodz<strong>in</strong>sky, A.J. Self-assembl<strong>in</strong>g peptide<br />

hydrogel fosters chondrocyte extracellular matrix production <strong>and</strong> cell division: implications for cartilage tissue<br />

repair. Proc. Natl. Acad. Sci. USA 99, 9996-1001 (2002).<br />

12) Zhang, S. Emerg<strong>in</strong>g biological materials through molecular self-assembly. Biotechnology Advances 20: 321–<br />

339(2002).<br />

13) Altman, M., Lee, P., Rich, A. & Zhang, S. Conformational behavior of ionic self-complementary peptides Prote<strong>in</strong><br />

Science 9 1095-1105 (2000).<br />

14) Holmes, T. Delacalle, S., Su, X., Rich, A., Zhang, S. Extensive neurite outgrowth <strong>and</strong> active neuronal synapses<br />

on peptide scaffolds. Proc. Natl. Acad. Sci. USA 97, 6728-6733 (2000).<br />

15) Zhang, S., Yan, L., Altman, M., Lässle, M., Nugent, H., Frankel, F., Lauffenburger, D., Whitesides, G. & Rich, A.<br />

Biological surface eng<strong>in</strong>eer<strong>in</strong>g: A simple system for cell pattern formation. Biomaterials 20, 1213-1220 (1999).<br />

16) Leon, Erasmo J. et al. Mechanical properties of a self-assembl<strong>in</strong>g oligopeptide matrix. J. Biomater. Sci.<br />

Polymer Edn. 9.3: 297-312 (1998).<br />

17) Zhang, S., Holmes, T., DiPersio, M., Hynes, R.O., Su, X. & Rich, A. Self-complementary oligopeptide matrices<br />

support mammalian cell attachment. Biomaterials 16, 1385-1393 (1995).<br />

18) Zhang, S., Holmes, T., Locksh<strong>in</strong>, C. & Rich, A. Spontaneous assembly of a self-complementary oligopeptide to<br />

form a stable macroscopic membrane. Proc. Natl. Acad. Sci. USA 90, 3334-3338 (1993).<br />

<strong>3DM</strong>, INC • PO BOX 425025 • CAMBRIDGE, MASSACHUSETTS • 02445 USA<br />

WWW.PURAMATRIX.COM • EMAIL: CONTACT@PURAMATRIX.COM • PHONE: 877.430.9595 • FAX: 877.430.9595

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!